NCT00840710

Brief Summary

The Study purpose is to monitor the cervix dilation, head descent, FHR and to follow contraction in a women in active labor.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2010

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 10, 2009

Completed
12 months until next milestone

Study Start

First participant enrolled

February 1, 2010

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2010

Completed
Last Updated

December 29, 2009

Status Verified

February 1, 2009

First QC Date

February 8, 2009

Last Update Submit

December 27, 2009

Conditions

ObstetricsLabor

Keywords

women in active labor

Eligibility Criteria

Age17 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women in active labor

You may qualify if:

  • Laboring women referred to the Maternity Center in active labor (3cm dilatation and contractions).
  • Gestational age 37-42 weeks. (GA)
  • Single fetus
  • Subjects who understood, agreed and signed the informed consent form

You may not qualify if:

  • Women with abnormal placentation (placenta previa)
  • Abnormal fetal presentation (breech presentation)
  • Maternal History of HIV and/or blood transmitted hepatitis and/or active genital Herpes.
  • Need for immediate delivery (cord prolapsed or suspected placental abruption)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Westren Gallilie Hospital

Nahariya, Israel

Location

Study Officials

  • Jacob Bornstein, PhD

    Westren Gallilie Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jacob Bornestein, Phd.

CONTACT

049107207

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 8, 2009

First Posted

February 10, 2009

Study Start

February 1, 2010

Study Completion

August 1, 2010

Last Updated

December 29, 2009

Record last verified: 2009-02

Locations

IL(1)